Diagnosis of immune checkpoint inhibitor-associated myocarditis: A systematic review von Pradhan, Richeek, Nautiyal, Amit, Singh, Sonal

Volltext

Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis von Makam, Raghavendra Charan P, Hoaglin, David C, McManus, David D, Wang, Victoria, Gore, Joel M, Spencer, Frederick A, Pradhan, Richeek, Tran, Hoang, Yu, Hong, Goldberg, Robert J

Volltext

India's ban on antimicrobial fixed-dose combinations: winning the battle, losing the war? von Sulis, Giorgia, Pradhan, Richeek, Kotwani, Anita, Gandra, Sumanth

Volltext

Centralised versus local measurement of glycated haemoglobin in clinical trial settings: a comment on Arch et al., Trials. 2016 von Chatterjee, Sudip, Pradhan, Richeek

Volltext

Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study von Pradhan, Richeek, Yu, Oriana H Y, Platt, Robert W, Azoulay, Laurent

Volltext

Re-examining the notion of irrational antimicrobial prescribing in LMICs von Chaudhuri, Sambuddha, Pradhan, Richeek

Volltext

Comparison of Data on Serious Adverse Events and Mortality in ClinicalTrials.gov, Corresponding Journal Articles, and FDA Medical Reviews: Cross-Sectional Analysis von Pradhan, Richeek, Singh, Sonal

Volltext

Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes von Pradhan, Richeek, Yin, Hui, Yu, Oriana, Azoulay, Laurent

Volltext

Pradhan et al. Respond to “Large-Scale, Multisite Studies Using Real-World Data” von Pradhan, Richeek, Patorno, Elisabetta, Azoulay, Laurent

Volltext

Can systemically generated reactive oxygen species help to monitor disease activity in generalized vitiligo? A pilot study von Pradhan, Richeek, De, Soumita, Choudhary, Nidhi, Mukherjee, Shibabrata, Chatterjee, Gobinda, Ghosh, Arghyaprasun, Chatterjee, Mitali, Chatterjee, Suparna

Volltext

Proton pump inhibitors and the risk of inflammatory bowel disease: population-based cohort study von Abrahami, Devin, Pradhan, Richeek, Yin, Hui, Yanofsky, Russell, McDonald, Emily Gibson, Bitton, Alain, Azoulay, Laurent

Volltext

Use of Real‐World Data to Emulate a Clinical Trial and Support Regulatory Decision Making: Assessing the Impact of Temporality, Comparator Choice, and Method of Adjustment von Abrahami, Devin, Pradhan, Richeek, Yin, Hui, Honig, Peter, Baumfeld Andre, Elodie, Azoulay, Laurent

Volltext

Clinical trial transparency at McGill University von Richeek Pradhan, Olivia Bonardi

Volltext

Sa1787 PROTON PUMP INHIBITORS AND THE RISK OF INFLAMMATORY BOWEL DISEASE: A REAL WORLD POPULATION-BASED COHORT STUDY von Yanofsky, Russell, Abrahami, Devin, Pradhan, Richeek, Yin, Hui, McDonald, Emily G., Bitton, Alain, Azoulay, Laurent

Volltext

Automatic extraction of quantitative data from ClinicalTrials.gov to conduct meta-analyses von Pradhan, Richeek, Hoaglin, David C., Cornell, Matthew, Liu, Weisong, Wang, Victoria, Yu, Hong

Volltext

Knowledge and perception regarding clinical trials among doctors of government medical colleges: A questionnaire-based study von Choudhury, Supriyo, Pradhan, Richeek, Dubey, Lily, Barman, Lisa, Biswas, Tanmoy, Das, Manisha, Chatterjee, Suparna

Volltext

Clinical trial transparency at McGill University von Pradhan, Richeek, Bonardi, Olivia

Volltext

1386-P: Dipeptidyl Peptidase-4 Inhibitors and the Risk of Skin Cancer among Patients with Type 2 Diabetes—Population-Based Cohort Study von PRADHAN, RICHEEK, AZOULAY, LAURENT, PLATT, ROBERT W., HOI YUN YU, ORIANA

Volltext

Long-Term patterns of cancer incidence among patients with and without type 2 diabetes in the United Kingdom von Pradhan, Richeek, Yu, Oriana, Platt, Robert W., Azoulay, Laurent

Volltext

Abstract #1088: High Thyroid Stimulating Hormone Level in Down’s Syndrome A Mere Resetting of Hypothalamopituitary Axis?: A Casecontrol Study von Sanyal, Debmalya, Pradhan, Richeek

Volltext